Results 21 to 30 of about 229,235 (203)

Methicillin-resistant Staphylococcus pseudintermedius: an underestimated risk at pet clinic [PDF]

open access: yesBrazilian Journal of Veterinary Medicine, 2020
The prevalence of methicillin-resistant Staphylococcus pseudintermedius (MRSP) as a cause of infectious disease in companion animals remains unknown.
Theresse Holmstrom   +7 more
doaj   +2 more sources

Complete Genome Sequence of the Canine Pathogen Staphylococcus pseudintermedius [PDF]

open access: yesJournal of Bacteriology, 2011
We report the first whole-genome sequence for a clinical isolate of Staphylococcus pseudintermedius (ED99), the major pathogen responsible for canine bacterial pyoderma. S.
Bannoehr, J.   +14 more
core   +8 more sources

Methicillin-Resistant Staphylococcus pseudintermedius in Rats

open access: yesEmerging Infectious Diseases, 2013
To the Editor: Staphylococcus pseudintermedius is a coagulase-positive species in the S. intermedius group. Previously misidentified as S. intermedius, S. pseudintermedius is now recognized as a leading cause of opportunistic infection in dogs (1) and a cause of sporadic infections in other species, including humans (1,2).
Chelsea Gardner Himsworth   +4 more
doaj   +3 more sources

Genomic dynamics of antimicrobial resistance in canine and human derived Staphylococcus pseudintermedius [PDF]

open access: yes, 2022
Staphylococcus pseudintermedius is a bacterium found on the skin and mucous membranes of healthy dogs. Generally, the bacteria is harmless, but the bacteria can also cause infections, such as ear and skin infections.
Wegener, Alice Christiane Helma
core   +3 more sources

Diverse Populations of Staphylococcus pseudintermedius Colonize the Skin of Healthy Dogs [PDF]

open access: yes, 2023
Staphylococcus pseudintermedius is a commensal bacterium of the canine skin but is also a key opportunistic pathogen that is responsible for most cases of pyoderma in dogs.
Ferrer, Lluís   +6 more
core   +1 more source

Expression and function of protein A in Staphylococcus pseudintermedius [PDF]

open access: yesVirulence, 2018
Staphylococcus pseudintermedius is an opportunistic pathogen in dogs and the most frequent cause of canine pyoderma. Protein A, a potent virulence factor in S. aureus is encoded by the spa gene. S. pseudintermedius possesses genes seemingly analogous to spa, but the expression and the characteristics of their products have not been directly determined.
Manasi Balachandran   +2 more
openaire   +3 more sources

Burden and predictors of Staphylococcus aureus and S. pseudintermedius infections among dogs presented at an academic veterinary hospital in South Africa (2007–2012) [PDF]

open access: yesPeerJ, 2017
Background Staphylococci are commensals of the mucosal surface and skin of humans and animals, but have been implicated in infections such as otitis externa, pyoderma, urinary tract infections and post-surgical complications.
Daniel N. Qekwana   +3 more
doaj   +2 more sources

Prevalence of Mupirocin Resistance in Staphylococcus pseudintermedius [PDF]

open access: yesJournal of Clinical Microbiology, 2014
ABSTRACT In the United States, veterinary use of mupirocin is primarily limited to the treatment of canine pyoderma caused by methicillin-resistant Staphylococcus pseudintermedius (MRSP). In this study, only 1 of 581 S. pseudintermedius isolates tested was resistant to mupirocin and
Stacey M, Godbeer   +2 more
openaire   +2 more sources

A spinal infection withStaphylococcus pseudintermedius [PDF]

open access: yesBMJ Case Reports, 2017
We present a case of a 60-year-old woman with an invasive spinal infection withStaphylococcus pseudintermediusassociated with a 15-year-old spinal fixation device and epidemiological contact with dogs. It was confirmed on blood culture and culture from pus from the epidural abscess and successfully treated using similar treatment as for aStaphylococcus
Christopher A Darlow   +3 more
openaire   +2 more sources

Inhibition of Staphylococcus pseudintermedius Efflux Pumps by Using Staphylococcus aureus NorA Efflux Pump Inhibitors

open access: yesAntibiotics, 2023
One promising approach in treating antibiotic-resistant bacteria is to “break” resistances connected with antibacterial efflux by co-administering efflux pump inhibitors (EPIs) with antibiotics.
Elisa Rampacci   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy